Spravato (esketamine) is a prescription drug that’s approved to treat certain forms of depression. Esketamine comes as a nasal spray that you inhale. Specifically, Spravato is approved by the ...

This is when a patient has tried multiple forms of treatment for major depression—usually at ... The drug is provided as a single-use nasal spray. This application means it's absorbed directly ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment cheaper for thousands of Australians.

It is the first new medicine to treat depression funded by the Australian government in over 30 years. Image: iStock Esketamine nasal spray will soon be subsidised under the Pharmaceutical ...

Nevada Mental Health, one of the state’s largest psychiatric practices, just started offering SPRAVATO®, a nasal mist ...

The drug is provided as a single-use nasal spray . This application means ... need to have been diagnosed with treatment-resistant depression . In practice, this means they will have ...

This is when a patient has tried multiple forms of treatment for major depression – usually at ... The drug is provided as a single-use nasal spray. This application means it’s absorbed ...